Cunningham B A, Hoffman S, Rutishauser U, Hemperly J J, Edelman G M
Proc Natl Acad Sci U S A. 1983 May;80(10):3116-20. doi: 10.1073/pnas.80.10.3116.
Chemical analyses and binding studies have been correlated to clarify the relationship of structure to function in the neural cell adhesion molecule (N-CAM) from embryonic chicken brain. N-CAM isolated from the cell surface appears to include two closely related polypeptide chains. Treatment with neuraminidase of such preparations of N-CAM bound by antibodies on solid supports yielded components of Mr 140,000 and 170,000. These components each had the same amino-terminal sequence as N-CAM and gave nearly identical profiles on peptide maps. Immunoprecipitation of N-CAM from 9-day brain cells treated with tunicamycin yielded corresponding components of Mr 130,000 and 160,000, suggesting that the differences between these two components of N-CAM are in the polypeptide rather than the carbohydrate portions of the molecules. N-CAM appears to be oriented with the amino terminus extending away from the cell surface and with the bulk of the sialic acid near the middle of the peptide chain. As shown previously, incubation of N-CAM at 37 degrees C generates a fragment (Fr1) of Mr 65,000 that lacks most of the sialic acid. Treatment of membranes with Staphylococcus aureus V-8 protease released a fragment (Fr2) of N-CAM that contained most of the sialic acid; this fragment had an Mr of 108,000 after neuraminidase treatment. Both of these fragments contain the amino-terminal portion of the polypeptide chain. At least a portion of the N-CAM binding site was found to be located in the amino-terminal region of the peptide chain. Most or all of the sialic acid was not directly involved in binding, although it can influence binding, as indicated by the finding that neuraminidase-treated N-CAM (desialylated-N-CAM) bound to cells to a greater extent than untreated N-CAM. The Fr1 and the Fr2 fragments in solution did not bind to cells but were as effective as N-CAM and desialylated-N-CAM as competitors for N-CAM binding to cells. When fixed covalently to beads, N-CAM, desialylated-N-CAM, and the Fr1 and Fr2 fragments bound specifically to cells. In contrast, the N-CAM autolysis products released along with Fr1 neither bound to cells nor competed for N-CAM binding. In addition to suggesting a location for the N-CAM binding region, the accumulated results raise the possibility that valence may play a key role in N-CAM binding.
化学分析和结合研究相互关联,以阐明来自鸡胚脑的神经细胞粘附分子(N-CAM)的结构与功能之间的关系。从细胞表面分离的N-CAM似乎包含两条密切相关的多肽链。用神经氨酸酶处理固定支持物上由抗体结合的此类N-CAM制剂,产生了分子量为140,000和170,000的组分。这些组分各自具有与N-CAM相同的氨基末端序列,并且在肽图上给出几乎相同的图谱。用衣霉素处理9天大的脑细胞后对N-CAM进行免疫沉淀,产生了分子量为130,000和160,000的相应组分,这表明N-CAM的这两种组分之间的差异在于分子的多肽部分而非碳水化合物部分。N-CAM似乎以氨基末端远离细胞表面且大部分唾液酸靠近肽链中部的方式定向。如先前所示,在37℃下孵育N-CAM会产生一个分子量为65,000的片段(Fr1),该片段缺乏大部分唾液酸。用金黄色葡萄球菌V-8蛋白酶处理膜会释放出一个包含大部分唾液酸的N-CAM片段(Fr2);经神经氨酸酶处理后,该片段的分子量为108,000。这两个片段都包含多肽链的氨基末端部分。发现至少部分N-CAM结合位点位于肽链的氨基末端区域。大部分或所有唾液酸并不直接参与结合,尽管它可以影响结合,如下述发现所示:经神经氨酸酶处理的N-CAM(去唾液酸化-N-CAM)比未处理的N-CAM与细胞的结合程度更高。溶液中的Fr1和Fr2片段不与细胞结合,但作为N-CAM与细胞结合的竞争者,其效果与N-CAM和去唾液酸化-N-CAM相同。当共价固定在珠子上时,N-CAM、去唾液酸化-N-CAM以及Fr1和Fr2片段特异性地与细胞结合。相反,与Fr1一起释放的N-CAM自溶产物既不与细胞结合,也不竞争N-CAM与细胞的结合。除了表明N-CAM结合区域的位置外,积累的结果还增加了价态可能在N-CAM结合中起关键作用的可能性。